CMN Intelligence
The world’s most comprehensive intelligence platform for CRISPR-Genomic Medicine and gene-editing clinical development.
Providing market intelligence, data infrastructure, analytics, and reporting services for the global gene-editing sector.
CMNtrials Global Report (>250 trials)
First Edition: 2025 (available January 2026)
This report includes detailed insights on:
Disease/Indication
Age Eligibility
Trial Locations (by country)
Trial Type
Trial Status
Phase
Sponsor
Therapeutic Candidate
Target Gene(s)
Editing Approach
Type of Edit
Editing Modality
Delivery Vehicle for Gene-Editing Reagents
Delivery Vehicle for Repair Template
Delivery Format for Gene-Editing Reagents
Delivery Format for Repair Template
Route of Administration
Regulatory Designations
Marketing Authorization
Reserve your copy here of the inaugural CMNtrials Global Report 2025.
Limited to 30 licenses - 10 already reserved.
Request further details regarding license availability for 2026.
